Protein Sciences To Begin Selling Novel Flu Vaccine; Flublok Has Virus-Free Appeal

The trivalent vaccine can be produced much faster than traditional vaccines and could be modified to compete with quadrivalent formulations.

Protein Sciences Corp. finally got FDA approval of its recombinant flu vaccine Flublok and hopes to release 150,000 doses for the current flu season by the end of the month.

Flublok is the first trivalent flu vaccine that is produced without eggs or live influenza virus. As a result, Protein Sciences says Flublok is manufactured in a fraction of the...

More from Approvals

More from Product Reviews

US FDA Meeting Drought Ends … With A Vengeance

 

The first 100 days of the Trump Administration were notable for an extraordinary decline in the number of public meetings hosted by the US Food and Drug Administration. But the schedule changed quickly.

EU CHMP Opinions And MAA Updates

 

This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.

HHS Rescinds COVID-19 Vaccine Advice, Usurping US CDC Role

 
• By 

By stepping into the role of the Centers for Disease Control and Advisory Committee on Immunization Practices, HHS Secretary Robert F. Kennedy Jr. is causing further confusion and uncertainty about vaccine policy, experts say.